Cargando…

Nonalcoholic steatohepatitis: A scientometric analysis of publications during 1980–2018

BACKGROUND: Nonalcoholic steatohepatitis (NASH) is a subtype of non-alcoholic fatty liver disease (NAFLD) with a potentially progressive course to liver fibrosis, cirrhosis with its complications, or even hepatocellular carcinoma. NAFLD is a rapidly growing chronic liver disease, with a global preva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trifan, Anca, Stanciu, Carol, Jurcău, Monica, Zenovia, Sebastian, Frunzuc, Georgiana, Timofte, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922426/ https://www.ncbi.nlm.nih.gov/pubmed/31852081 http://dx.doi.org/10.1097/MD.0000000000018221

Ejemplares similares

Crohn’s disease from past to present: Research trends and global outcomes with scientometric analysis during 1980 to 2022
por: Karabulut, Alpaslan, et al.
Publicado: (2023)

Eosinophilic esophagitis in an octogenarian: A case report and review of the literature
por: Trifan, Anca, et al.
Publicado: (2016)

Use of a Diabetes Self-Assessment Score to Predict Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Kim, Gyuri, et al.
Publicado: (2015)

Thyroid-stimulating hormone is associated with nonalcoholic steatohepatitis in patients with chronic hepatitis B
por: Liu, Liang, et al.
Publicado: (2019)

Clinical and sociodemographic determinants of disease progression in patients with nonalcoholic steatohepatitis in the United States
por: Ruiz-Casas, Leonardo, et al.
Publicado: (2021)

Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain
por: Romero-Gomez, Manuel, et al.
Publicado: (2020)

Efficacy and safety of acetyl-CoA carboxylase (ACC) inhibitors in the treatment of nonalcoholic steatohepatitis (NASH): A protocol for systematic review
por: Xu, Liubin, et al.
Publicado: (2022)

Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients
por: Tai, Chi-Ming, et al.
Publicado: (2016)

Sarcoidosis associated with infliximab therapy in ulcerative colitis: A case report
por: Gîlcă, Georgiana-Emmanuela, et al.
Publicado: (2017)

Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases: The Heart of the Matter
por: Chiriac, Stefan, et al.
Publicado: (2021)

Association between Nonalcoholic Fatty Liver Disease and Endocrinopathies: Clinical Implications
por: Singeap, Ana-Maria, et al.
Publicado: (2021)

A Descriptive Review on the Prevalence of Gastrointestinal Disturbances and Their Multiple Associations in Autism Spectrum Disorder
por: Lefter, Radu, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship
por: Muzica, Cristina M., et al.
Publicado: (2020)

Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or older
por: Trifan, Anca, et al.
Publicado: (2017)

The Relation between Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis and Different Cannulation Techniques: The Experience of a High-Volume Center from North-Eastern Romania
por: Chiriac, Stefan, et al.
Publicado: (2023)

Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for the Diagnosis of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
por: Zenovia, Sebastian, et al.
Publicado: (2021)

Development of de novo nonalcoholic fatty liver disease following pancreatectomy
por: Patel, Vanisha, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis
por: Sinn, Dong Hyun, et al.
Publicado: (2016)

Risk factors of nonalcoholic fatty liver disease in healthy women
por: Guan, Hui, et al.
Publicado: (2023)

Nonalcoholic fatty liver was associated with asymptomatic gallstones in a Chinese population
por: Qiao, Qiao-Hua, et al.
Publicado: (2017)

Efficacy of probiotics on nonalcoholic fatty liver disease: A meta-analysis
por: Zhou, Xiangyu, et al.
Publicado: (2023)

The metabolic influence of duodenal mucosal resurfacing for nonalcoholic fatty liver disease
por: Chuang, Te-Jung, et al.
Publicado: (2023)

Hepatocellular carcinoma after direct-acting antiviral hepatitis C virus therapy: A debate near the end
por: Muzica, Cristina Maria, et al.
Publicado: (2020)

Association of resting heart rate with nonalcoholic fatty liver disease in postmenopausal women
por: Kim, Hong-Bae, et al.
Publicado: (2020)

A nomogram incorporated lifestyle indicators for predicting nonalcoholic fatty liver disease
por: Peng, Kaili, et al.
Publicado: (2021)

Therapeutic effects of sleeve gastrectomy for non-alcoholic steatohepatitis estimated by paired liver biopsy in morbidly obese Japanese patients
por: Murakami, Eisuke, et al.
Publicado: (2021)

The Presence of White Matter Lesions Is Associated With the Fibrosis Severity of Nonalcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2016)

Nonalcoholic Fatty Liver Disease: A Negative Risk Factor for Colorectal Cancer Prognosis
por: You, Jie, et al.
Publicado: (2015)

Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)
por: Golabi, Pegah, et al.
Publicado: (2018)

Candidate genes investigation for severe nonalcoholic fatty liver disease based on bioinformatics analysis
por: Qi, Shan, et al.
Publicado: (2017)

Association between Helicobacter pylori infection and nonalcoholic fatty liver: A meta-analysis
por: Liu, Rongqiang, et al.
Publicado: (2019)

Reversal of nonalcoholic fatty liver disease reduces the risk of cardiovascular disease among Korean
por: Oh, Yun Hwan, et al.
Publicado: (2023)

Epigenetic Modifications in the Biology of Nonalcoholic Fatty Liver Disease: The Role of DNA Hydroxymethylation and TET Proteins
por: Pirola, Carlos J., et al.
Publicado: (2015)

Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese
por: Huang, Xiaolin, et al.
Publicado: (2015)

The expression of thymosin β4 in chronic hepatitis B combined nonalcoholic fatty liver disease
por: Liang, Jing, et al.
Publicado: (2016)

Nonalcoholic Cirrhosis Increased Risk of Digestive Tract Malignancies: A Population-Based Cohort Study
por: Sun, Li-Min, et al.
Publicado: (2015)

Cost-effectiveness analysis of ultrasonography screening for nonalcoholic fatty liver disease in metabolic syndrome patients
por: Phisalprapa, Pochamana, et al.
Publicado: (2017)

Comparison of noninvasive scoring systems for the prediction of nonalcoholic fatty liver disease in metabolic syndrome patients
por: Saokaew, Surasak, et al.
Publicado: (2020)

Soy diet for nonalcoholic fatty liver disease: A meta-analysis of randomized controlled trials
por: Xiong, Pian, et al.
Publicado: (2021)

Decline in serum albumin concentration is a predictor of serious events in nonalcoholic fatty liver disease
por: Kawaguchi, Kazunori, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cavjk13k8q7tbt17v5qh4t4gek